These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16598671)

  • 1. Quantitative cell-cycle protein expression in oral cancer assessed by computer-assisted system.
    Soares CP; Zuanon JA; Teresa DB; Fregonezi PA; Neto CB; Oliveira MR; Donadi EA; Martinelli-Kläy CP; Soares EG
    Histol Histopathol; 2006 Jul; 21(7):721-8. PubMed ID: 16598671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoblastoma and p53 protein expression in pre-malignant oral lesions and oral squamous cell carcinoma.
    de Oliveira MG; Ramalho LM; Gaião L; Pozza DH; de Mello RA
    Mol Med Rep; 2012 Jul; 6(1):163-6. PubMed ID: 22576742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias.
    Nasser W; Flechtenmacher C; Holzinger D; Hofele C; Bosch FX
    J Oral Pathol Med; 2011 Sep; 40(8):629-35. PubMed ID: 21435003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.
    Wood MW; Medina JE; Thompson GC; Houck JR; Min KW
    Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-assisted analysis of p53 and PCNA expression in oral lesions infected with human papillomavirus.
    Soares CP; Benatti Neto C; Fregonezi PA; Teresa DB; Santos RT; Longatto Filho A; Maeda MY
    Anal Quant Cytol Histol; 2003 Feb; 25(1):19-24. PubMed ID: 12630078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
    Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
    J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Girod SC; Pfeiffer P; Ries J; Pape HD
    Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer-assisted analysis of cell proliferation markers in oral lesions.
    Teresa DB; Neves KA; Neto CB; Fregonezi PA; de Oliveira MR; Zuanon JA; Donadi EA; Mendes-Junior CT; Soares CP
    Acta Histochem; 2007; 109(5):377-87. PubMed ID: 17706749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features and immunohistochemical expression of p53, Ki-67, Mcm-2 and Mcm-5 in proliferative verrucous leukoplakia.
    Gouvêa AF; Vargas PA; Coletta RD; Jorge J; Lopes MA
    J Oral Pathol Med; 2010 Jul; 39(6):447-52. PubMed ID: 20412398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
    Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
    Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
    Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia.
    Kaur J; Matta A; Kak I; Srivastava G; Assi J; Leong I; Witterick I; Colgan TJ; Macmillan C; Siu KW; Walfish PG; Ralhan R
    Int J Cancer; 2014 Mar; 134(6):1379-88. PubMed ID: 24122701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p53, epidermal growth factor receptor, c-erbB2 in oral leukoplakias and oral squamous cell carcinomas.
    Singla S; Singla G; Zaheer S; Rawat DS; Mandal AK
    J Cancer Res Ther; 2018; 14(2):388-393. PubMed ID: 29516925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of p53, bcl-2, and Ki-67 immunoreactivity and of apoptosis in normal oral epithelium and in premalignant and malignant lesions of the oral cavity.
    Piattelli A; Rubini C; Fioroni M; Iezzi G; Santinelli A
    J Oral Maxillofac Surg; 2002 May; 60(5):532-40. PubMed ID: 11988932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midkine expression in oral squamous cell carcinoma and leukoplakia.
    Jham BC; Costa NL; Silva JM; de Miranda AC; Oliveira JC; Silva TA; Batista AC
    J Oral Pathol Med; 2012 Jan; 41(1):21-6. PubMed ID: 21595751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of integrin-beta1 in oral leukoplakia and early invasive carcinoma and its relationship with cell proliferation].
    Shang JW; Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Oct; 43(10):608-11. PubMed ID: 19087624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical Expression of Podoplanin in Clinical Variants of Oral Leukoplakia and Its Correlation With Epithelial Dysplasia.
    D'souza B; Nayak R; Kotrashetti VS
    Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):132-139. PubMed ID: 27153448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders.
    Abrahao AC; Bonelli BV; Nunes FD; Dias EP; Cabral MG
    Braz Oral Res; 2011; 25(1):34-41. PubMed ID: 21359449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues.
    Fan GK; Chen J; Ping F; Geng Y
    Oral Oncol; 2006 Feb; 42(2):147-53. PubMed ID: 16246616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actual proliferating index in oral squamous cell carcinoma and leukoplakia.
    Chandak AR; Gadbail AR; Chaudhary MS; Chandak SA; Wadhwani R
    J Investig Clin Dent; 2011 Aug; 2(3):176-83. PubMed ID: 25426788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.